Overview

Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women

Status:
Completed
Trial end date:
2018-07-31
Target enrollment:
Participant gender:
Summary
Assessment of the effectiveness of Enoxaparin, at a preventive dose, combined with Aspirin treatment versus Aspirin only treatment in reducing placental insufficiency in pregnant women.
Phase:
Phase 4
Details
Lead Sponsor:
Les Laboratoires des Médicaments Stériles
Treatments:
Aspirin
Enoxaparin